117 related articles for article (PubMed ID: 2025884)
1. Monoclonal antibody 323/A3: a marker for the presence of breast carcinoma.
Courtney SP; Williams S; Mansel RE
Cancer Lett; 1991 May; 57(2):115-9. PubMed ID: 2025884
[TBL] [Abstract][Full Text] [Related]
2. Can monoclonal antibody staining by 323/A3 and Ca1 of benign breast biopsies predict the development of breast cancer?
Courtney SP; Williams S; Mansel RE
J Cancer Res Clin Oncol; 1993; 119(3):127-30. PubMed ID: 8418084
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies 323/A3 and Ca1 identify a paracrine function of breast carcinoma on adjacent benign histological components.
Courtney SP; Williams S; Mansel RE
Br J Cancer Suppl; 1990 Jul; 10():92-5. PubMed ID: 1696492
[TBL] [Abstract][Full Text] [Related]
4. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
Förster C; Bässler R
Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
[No Abstract] [Full Text] [Related]
5. A critical investigation of the Oxford tumour marker Ca1 in the histological diagnosis of breast cancer and pre-cancer.
Simpson HW; Candlish W; Liddle C; McGregor M; Mutch F; Tinkler B
Histopathology; 1984 May; 8(3):481-99. PubMed ID: 6376326
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody B72.3 in benign breast lesions.
Soomro S; Shousha S
J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues.
Werner M; von Wasielewski R; Bernhards J; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):411-6. PubMed ID: 2156377
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
10. Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy.
Beckford U; Barbatis C; Beesley JE; Linsell JC; Chantler SM
J Clin Pathol; 1985 May; 38(5):512-20. PubMed ID: 3889068
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
Berry N; Jones DB; Smallwood J; Taylor I; Kirkham N; Taylor-Papadimitriou J
Br J Cancer; 1985 Feb; 51(2):179-86. PubMed ID: 2578285
[TBL] [Abstract][Full Text] [Related]
12. Human tumor and normal tissue reactivity of the anti-(breast cancer) monoclonal antibody BA-Br-3 and its similarity to the anti-(epithelial membrane antigen) monoclonal antibody E29.
Liao SK; Flahart RE; Kimbro B; Horton L; Oldham RK; Hilgers J; van der Gaag R
Cancer Immunol Immunother; 1990; 31(2):65-75. PubMed ID: 2182192
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer mucin: an automated assay to detect mucus glycoproteins.
Bonfrer JM; de Graaf HM; Nooijen WJ
Tumour Biol; 1992; 13(3):162-7. PubMed ID: 1626180
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen-regulated 24-kDa protein--a marker for breast carcinoma in benign breast tissue.
Courtney SP; Williams S; Mansel RE
J Cancer Res Clin Oncol; 1991; 117(6):593-6. PubMed ID: 1720785
[TBL] [Abstract][Full Text] [Related]
15. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
Rowe DJ; Beverley PC
Br J Cancer; 1984 Feb; 49(2):149-59. PubMed ID: 6365132
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions.
Walsh R; Peston D; Shousha S
Arch Pathol Lab Med; 2001 Jun; 125(6):781-4. PubMed ID: 11371230
[TBL] [Abstract][Full Text] [Related]
18. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.
Schmitt FC; Andrade L
J Clin Pathol; 1995 Jan; 48(1):53-6. PubMed ID: 7706519
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining patterns of benign breast biopsies by 323/A3 and Ca1 monoclonal antibodies related to epidemiological and radiological risk criteria.
Courtney SP; Williams S; Mansel RE
Int Surg; 1992; 77(1):55-9. PubMed ID: 1374368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
